2025. EVALUATION OF HBA1C AS A MARKER OF GLYCEMIC CONTROL AND DYSLIPIDEMIA IN TYPE 2 DIABETES. Frontier in Medical and Health Research. 3, 10 (Dec. 2025), 120–132.